Assessing Research Misconduct in Randomized Controlled Trials
Open accessAbstract
Randomized controlled trials (RCTs) serve as the pillar of evidence-based medicine and guide medical practice. Compromised data integrity in RCTs undermines the authority of this valuable tool for science and puts patients at risk. Although a large number of retractions due to data issues in obstetrics and gynecology have occurred in the past few years, many problematic RCTs could still go uncovered because in general there is insufficient willingness to envisage and confront research misconduct. In this article, we discuss the necessity of assessing research misconduct, summarize methods that have been applied in detecting previous cases of misconduct, and propose potential solutions. There is no established mechanism to monitor feedback on published articles and the current system that handles potential research misconduct is unsatisfactory. Fortunately, there are methods to assess data integrity in RCTs both with and without individual participant data. Investigations into research misconduct can be facilitated by assessing all publications from a leading author or author group to identify duplication and patterns of ongoing misconduct. There is a pressing need to improve the mechanism that investigates data manipulation. The mechanism that handles misconduct should prioritize the interests of patients and readers rather than trial authors and their institutions. An equally urgent issue is to establish mechanisms that prevent compromised trials from polluting evidence synthesis or misguiding practice.
AI snapshot
Written from the paper’s full text.
TL;DR
Data integrity problems in obstetrics and gynecology RCTs are under-detected, and current retraction and investigation systems are slow and inconsistent. The authors review detection approaches using summary statistics or individual participant data and propose checklists and policy actions to protect evidence synthesis and patient care.
Key findings
- A Retraction Watch search identified 36 obstetrics and gynecology RCTs retracted or under formal investigation for data-validity concerns; Japan (n=16) and Egypt (n=15) accounted for 86%, about 81% came from six first authors with multiple notices, and median publication-to-retraction was 11.2 years (IQR 4.3–13.3).
- In a prior examination of 35 RCTs by two authors, 21 had more than 10 identical or very similar values across baseline and outcome tables, suggesting repeated data patterns.
- Survey evidence cited: more than 14% of scientists reported observing fabrication or falsification by colleagues, while only 2% admitted such behavior; across medicine, retraction for misconduct averages almost 4 years.
- Detection can use summary statistics (e.g., recalculating P values, GRIMMER, SPRITE, Benford’s law, baseline P-value distributions) or individual participant data (e.g., repeated-measurement patterns, missingness, date rationality, correlation checks, central statistical monitoring), but no single method is definitive.
Methods
- Narrative/expert review with a targeted search of the Retraction Watch database on December 22, 2020, limited to subject “(HSC) Medicine-Obstetrics or Gynaecology” and article type “Clinical Study,” with no time restriction; excluded non-RCT, non-obstetrics/gynecology, or non-data-validity notices, retained retraction over prior expression of concern, and added known recent notices.
- The authors summarize published detection methods and propose an integrity checklist for RCTs plus action points for journals, publishers, institutions, evidence synthesizers, and others.
- No formal meta-analysis or primary validation study is reported; the Retraction Watch results are descriptive.
Limitations
- Stated: the proposed RCT integrity checklist has not been formally validated, and the appropriate threshold for triggering investigation is unknown; the REAPPRAISED checklist was piloted but lacks formal validation.
- Stated: current mechanisms are inconsistent; COPE guidance relies heavily on author and institution responses, monitoring post-publication feedback is absent, and data sharing or individual participant data availability is uncommon.
- Stated method-specific limits: Statcheck cannot process tables and may be limited to APA formats; GRIMMER only works for sample sizes of 99 or less; Benford’s law has high sensitivity but poor specificity; baseline P-value methods depend on debated assumptions. Evident from the text: the Retraction Watch search is limited to one specialty and database, so it likely undercounts misconduct, and the article is an expert commentary rather than a systematic prevalence study.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 53 cited sources checked · 0 supported · 0 flagged
- Findingnone given
A Cochrane CENTRAL search identified more than 48,000 obstetrics and gynecology RCTs from inception.
“a search of RCTs regarding obstetrics and gynecology in Cochrane CENTRAL identified more than 48,000 RCTs from inception.”
Quote in the paperNot a substantial claim - Findingown data
One third of the identified articles were published before 2005, when trial registration and similar precautions were not yet in place.
“One third of these articles were published before 2005, when precautionary measures such as trial registration have not been introduced.”
Quote in the paperNot a substantial claim - Findingown data
About 81% of the identified studies came from six first authors who had multiple retractions or expressions of concern.
“About 81% of identified studies were published by six first authors who had multiple retractions or expressions of concern.”
Quote in the paperSubstantial claim - Findingown data
Among the retraction or concern notices, studies from Japan and Egypt together accounted for 86%.
“Studies from Japan (n516) and Egypt (n515) account for 86% of the notices.”
Quote in the paperNot a substantial claim - Findingown data
In obstetrics and gynecology, 36 randomized controlled trials had been retracted or were under formal investigation because of data-validity concerns.
“A total of 36 RCTs in obstetrics and gynecology have been retracted or are undergoing formal investigations due to concerns related to data validity”
Quote in the paperSubstantial claim
- Premisereasoning
P-values in baseline characteristics tables are expected to approach a uniform distribution between 0 and 1, not all to exceed .05.
“In fact, P-values in the baseline characteristics table are expected to approach a uniform distribution between 0 and 1.”
Quote in the paperSubstantial claim - Premisecitation
It is possible to extract numbers from an article and assess whether first- and last-digit frequencies are consistent with Benford's law.
“It is possible to extract numbers in one article and assess whether the frequencies of the first digits and last digits are consistent with Benford's law.23,24”
Quote in the paperSubstantial claim0 of 2 sources checked - Interpretationreasoning
An excessive proportion of certain digits might indicate that authors unconsciously prefer those digits when fabricating numbers.
“An excessive proportion of certain digits might indicate that the authors unconsciously prefer these digits when making up numbers.”
Quote in the paperSubstantial claim - Premisecitation
Statcheck can extract reported statistical values from text to reproduce P-values.
“A software called Statcheck can extract reported statistical values from the text to reproduce the P-value for the reported statistical result.19”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [19] source
Not checked in the free run.
- Premisecitation
Data sharing remains uncommon for published RCTs.
“Although sharing of individual participant data has been encouraged for several years, 16 data sharing is still uncommon for published RCTs.17”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [16]
Not checked in the free run.
- cites [17] source
Not checked in the free run.
- Premisecitation
Chi-square tests, Fisher exact tests, odds ratios, and risk ratios can be reproduced using absolute numbers in crosstabs.
“Chi-square tests, Fisher exact tests, odds ratios, and risk ratios can be reproduced using absolute numbers given in crosstabs.18”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [18] source
Not checked in the free run.
- Premisecitation
Some articles in a series of fraudulent publications took more than 5 years to be retracted.
“It took more than 5 years for some articles in the series to be retracted.3”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [3] source
Not checked in the free run.
- Interpretationreasoning
Comparing all publications by a leading author or author group can reveal manipulation patterns unique to that author or group.
“comparing all publications of the leading author or author group being investigated may offer extra insights into the problem because certain patterns of data manipulation that are unique to the leading author or group can only be identified when all their works are analyzed and compared.”
Quote in the paperSubstantial claim - Premisenone given
Independent t tests and one-way analysis of variance can be reproduced from reported means, standard deviations, and sample sizes.
“Independent t test and one-way analysis of variance can be reproduced with reported means, SDs, and the sample size reported in articles.”
Quote in the paperSubstantial claim - Premisecitation
Publishers and journals are committed to the COPE retraction guidelines for handling misconduct issues.
“Publishers and journals are committed to retraction guidelines of COPE (the Committee on Publication Ethics) to handle misconduct issues.12”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [12] source
Not checked in the free run.
- Premisecitation
In cases involving the most prolific fraudulent authors, journals varied greatly in how they acted once evidence of massive fraud was confirmed.
“In cases of the most prolific authors who committed fraud, involved journals displayed huge variations in practice when mounting evidence confirmed massive fraud.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [3] source
Not checked in the free run.
- Interpretationnone given
Authors who fabricate trials may report accumulating many participants in a short period that exceeds their institution's capacity.
“Authors who fabricate trials may report a trial that accumulated a large number of participants in a short period that exceeded the capacity of their institutions.”
Quote in the paperNot a substantial claim - Interpretationreasoning
A placebo-controlled trial is unlikely to be performed without funding or manufacturer involvement.
“It is unlikely that a placebo-controlled trial can be performed without funding or the involvement of manufacturers.”
Quote in the paperSubstantial claim - Study design and conductnone given
A limitation of the all-publications comparison approach is that it becomes more demanding when the investigated subject has many publications.
“A shortfall of our approach is that this process becomes more demanding when the subject of the investigation has a large number of publications.”
Quote in the paperNot a substantial claim - Interpretationreasoning
The current system acts as a black box that prevents general readers from learning about investigations into the evidence they use until articles are retracted, often years after publication.
“The above-mentioned issues in the current system form a black box that hinders general readers from knowing investigations about the evidence they use until these articles are retracted suddenly, usually years after publication.”
Quote in the paperSubstantial claim- Rests on an assumption: In most research-misconduct investigations, authors and their institutions do not respond adequately or in a timely manner.
- Rests on an assumption: A lack of willingness to consider integrity issues in published articles often prolongs or prevents retraction of problematic articles.
- Rests on an assumption: Because regulatory oversight is usually absent, institutions have questionable motivation to investigate their employees' research.
- Interpretationreasoning
The true prevalence of research misconduct is extremely difficult to determine.
“However, a critical problem is that it is extremely difficult to understand the real prevalence of research misconduct.”
Quote in the paperNot a substantial claim - Interpretationreasoning
Some reported statistical results can be reproduced from summary data, especially univariable parametric analyses commonly used in RCTs.
“Some reported statistical results can be reproduced with summary data.This approach is especially suitable for univariable parametric analyses, which are commonly used in RCTs.”
Quote in the paperSubstantial claim - Premisecitation
Across all fields of medicine, articles labeled with research misconduct take almost 4 years on average to be retracted.
“On average, it takes almost 4 years for articles labeled with research misconduct to be retracted across all fields of medicine.11”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [11] source
Not checked in the free run.
- Interpretationreasoning
Recalculated P-values can be checked against reported P-values for inconsistencies.
“Recalculated P-values can then be checked against the reported P-values for inconsistencies.”
Quote in the paperSubstantial claim - Interpretationown data
Because the publication-to-retraction interval for obstetrics and gynecology RCTs with data issues is much longer than the general medicine average, barriers to retraction may be harder to overcome in this field.
“Judging from the much longer duration (11.2 years) from publication to retraction for RCTs with data issues in obstetrics and gynecology, these barriers could be more difficult to overcome in our field.”
Quote in the paperSubstantial claim - Interpretationreasoning
The balance of baseline-characteristic P-values produced by random allocation is not easily fabricated.
“This balance of P-values of baseline characteristics due to random allocation is not easily fabricated.”
Quote in the paperSubstantial claim - Premisecitation
When falsifying correlated data, correlations may become too strong or too weak to be plausible.
“When falsifying these data, the correlations may end up too strong or too weak to be plausible.34”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [34] source
Not checked in the free run.
- Premisecitation
These attempts are usually hindered by the current unavailability of data.
“Unfortunately, these attempts are usually hampered by the unavailability of data at present.46”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [46]
Not checked in the free run.
- Interpretationreasoning
The actual implementation of trial registration and CONSORT may not be satisfactory.
“More importantly, their actual implementation may not be satisfactory.”
Quote in the paperSubstantial claim - Premisecitation
RCTs that clearly violated the CONSORT statement can be published in peer-reviewed journals.
“We previously demonstrated that RCTs that clearly violated the CONSORT statement can be published in peer-reviewed journals.41”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [41]
Not checked in the free run.
- Interpretationreasoning
Central statistical monitoring can be applied to assess data integrity in a multicenter trial.
“It is possible to apply this method in the assessment of data integrity in a multicenter trial.”
Quote in the paperSubstantial claim- The authors state this as an assumption: In central statistical monitoring, it is assumed that anyone who manipulated data did not have access to trial data from other staff or centers.
- Interpretationnone given
Reproducing statistics from individual participant data is indispensable when assessing data integrity.
“Reproducing statistics using individual participant data is an indispensable step when assessing data integrity.”
Quote in the paperNot a substantial claim - Premisecitation
In trials with repeated measurements on the same individuals, propagating previous data to later data leads to insufficient variability between consecutive observations.
“For example, in trials with repeated measurements of outcomes on the same individuals, propagation of previous data to later data leads to insufficient variability between consecutive observations.34”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [34] source
Not checked in the free run.
- Interpretationreasoning
Statistical features such as missing-value patterns, value distributions, correlations between variables, and inliers can be compared between centers.
“Statistical aspects such as the missing value pattern, distribution of values, correlation between variables, and inliers can be compared between centers.”
Quote in the paperSubstantial claim- The authors state this as an assumption: In central statistical monitoring, it is assumed that anyone who manipulated data did not have access to trial data from other staff or centers.
- Interpretationnone given
It is difficult to fabricate several means and standard deviations for separate variables or groups in a way that emulates real data.
“It is also difficult to fabricate several means and SDs for separate variables or groups in a way that emulates real data.”
Quote in the paperNot a substantial claim - Interpretationreasoning
Some researchers have deliberately bypassed the registration rule.
“which means the rule of registration has been deliberately bypassed by some researchers.”
Quote in the paperSubstantial claim - Premisecitation
There have been examples of RCTs retracted for data-integrity reasons that had been prospectively registered.
“A more concerning issue is that there have been examples where retracted RCTs due to data integrity were prospectively registered, 42,43”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [42]
Not checked in the free run.
- cites [43]
Not checked in the free run.
- Premisecitation
Trials that share individual participant data perform better on quality and integrity than trials that do not share such data.
“We previously demonstrated that trials with individual participant data sharing have better performance on quality and integrity than trials without sharing.18”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [18] source
Not checked in the free run.
- Premisecitation
Inliers, meaning strange distributions of values too close to the overall study mean, indicate concerns about data integrity.
“Inliers that refer to strange distributions of values that are too close to the overall study mean indicate concerns regarding data integrity.36”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [36] source
Not checked in the free run.
- Interpretationcitation
Including all relevant studies to reduce publication bias in systematic reviews may be counterproductive, as it allows evidence from unverified trials to contaminate the review.
“The attempt to include all relevant studies to minimize the risk of publication bias in systematic reviews could be counterproductive because it facilitates contamination of evidence from unverified trials.41”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [41]
Not checked in the free run.
- Interpretationreasoning
Individual participant data meta-analyses have advantages for producing more reliable evidence, because the included data must pass quality and integrity checks.
“Individual participant data metaanalyses possess advantages in terms of generating more reliable evidence because those data included need to pass quality and integrity checks.”
Quote in the paperSubstantial claim - Premisecitation
Using reported baseline summary statistics, P-values can be calculated with parametric tests such as independent t tests or Monte Carlo simulations.
“Using reported summary statistics of baseline characteristics, P-values can be calculated with parametric tests such as independent t test 25 or Monte Carlo simulations.26”
Quote in the paperSubstantial claim0 of 2 sources checked - Interpretationreasoning
To avoid outliers, data manipulators may create many inliers, leading to very small variations.
“To avoid outliers, they may create a large number of inliers that lead to very small variations.”
Quote in the paperSubstantial claim - Premisecitation
Some retracted articles were cited more frequently after their retraction than before.
“This explains a paradoxical phenomenon that some retracted articles were cited far more often after their retractions.45”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [45]
Not checked in the free run.
- Interpretationreasoning
Assessing data integrity with individual participant data is more likely to provide solid evidence of misconduct than using summary statistics because it uses the abundance and complexity of hidden information in the data sets.
“The assessment of data integrity with individual participant data is more likely to provide solid evidence of misconduct compared with an evaluation of summary statistics because it benefits from the abundance and complexity of information hidden in the data sets (Table 2).”
Quote in the paperSubstantial claim - Premisecitation
Even high-impact journals continue to publish trials that do not meet the prospective registration standard.
“However, even high-impact journals continue to publish trials that do not meet this standard.40”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [40]
Not checked in the free run.
- Premisecitation
Comparing recruitment speed alongside time between treatment groups may reveal periods when treatment allocation was manipulated.
“Performing a comparison of recruitment speed alongside time between treatment groups may reveal periods during which treatment allocation was manipulated.34”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [34] source
Not checked in the free run.
- Premisecitation
These baseline P-value methods have been successfully applied in investigations of several research-misconduct cases.
“These methods have been successfully applied in the investigations of several cases of research misconduct.25,27,29”
Quote in the paperNot a substantial claim0 of 3 sources checked - Interpretationreasoning
Trial registration has been extremely helpful for detecting fabrication because inconsistencies in study start and end dates and sample size help uncover fraud.
“On the other hand, trial registration has been extremely helpful in the detection of fabrication, as inconsistencies regarding the start and end date of studies and sample size help to uncover fraud.”
Quote in the paperNot a substantial claim
- May combine two claims. 29
- Classified as probably not a substantial claim. 33
May combine two claims.
Findingown dataIn an examination of all RCTs by two authors from the same university, 21 of 35 evaluated trials had more than 10 identical or extremely similar values between trials, revealing a pattern of self-plagiarism of data.
“Using pairwise comparisons of baseline characteristics and outcome tables, for 21 of the 35 evaluated trials, more than 10 identical or extremely similar values between trials were observed, uncovering a pattern of self-plagiarism of data.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [14] source
Not checked in the free run.
Probably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing), S4 (based).
Findingnone givenIn the authors' experience, misconduct cases are likely to meet several checklist criteria.
“In our experience, cases of misconduct are likely to meet several of the criteria in the checklist.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe median time from publication to retraction was 11.2 years, with an interquartile range of 4.3 to 13.3 years.
“The median duration between publication to retraction was 11.2 years (interquartile range 4.3-13.3).”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningThere is no consistent protocol or motivation for monitoring feedback on articles after publication.
“There is no consistent protocol nor motivation to monitor feedback on articles once they are published”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S4 (based). May combine two claims.
Premisenone givenPlacebo preparation is technically challenging and usually requires involvement of the intervention manufacturers.
“Placebo preparation is technically challenging and usually requires the involvement of manufacturers of interventions.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Study design and conductnone givenThe authors could not determine the most appropriate threshold for triggering an investigation.
“We have not been able to determine the most appropriate threshold to trigger an investigation.”
Quote in the paperSubstantial claimMay combine two claims.
Premisenone givenNot all research numbers occur naturally, and some naturally occurring numbers may have unequal digit distributions, such as rounded laboratory readings.
“However, not all numbers in research occur naturally and some naturally occurring numbers may have unequal distributions of digits; for example, laboratory readings might be rounded.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationThe REAPPRAISED checklist supports systematic evaluation through 11 categories and can be used during manuscript review and postpublication evaluation.
“This checklist facilitates systematic evaluation through 11 categories and, as the authors suggested, can be used during both manuscript review and postpublication evaluation.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [15]
Not checked in the free run.
May combine two claims.
PremisecitationA validation study found that applying Benford's law to RCTs is unlikely to miss fraud cases (100% sensitivity) but may misclassify many controls as cases (poor specificity).
“A validation study using cases of fraud and nonverified controls found that applying Benford's law to RCTs is unlikely to miss cases (100% sensitivity) but may misclassify many controls as cases (poor specificity).23”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [23] source
Not checked in the free run.
Classified as probably not a substantial claim. May combine two claims.
Interpretationnone givenThe COPE guidelines use a rigid branching logic and depend heavily on responses from authors and their institutions.
“The COPE guidelines follow a rigid branching logic and rely heavily on responses from authors and their institutions.”
Quote in the paperSubstantial claim- Rests on an assumption: In most research-misconduct investigations, authors and their institutions do not respond adequately or in a timely manner.
May combine two claims.
PremisecitationGRIMMER can test variances, standard deviations, and standard errors.
“This method can test variances, SDs, and standard errors.”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationBenford's law describes digit distributions in naturally occurring numbers: first digits follow a special distribution with 1, 2, and 3 accounting for more than 60%, while last digits approach uniform distribution.
“Benford's law describes the distribution of the digits in naturally occurring numbers.23 The first digits tend to follow a special distribution where digits 1, 2, and 3 account for more than 60% of the total probability distribution.The last digits, however, approach uniform distribution.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [23] source
Not checked in the free run.
Probably not a substantial claim: may not pass S2 (checkable), S4 (based). May combine two claims.
Interpretationnone givenFew people have enough knowledge to detect data-integrity problems in RCTs, and no overview of available detection methods exists.
“However, few people are equipped with adequate knowledge to detect data integrity issues in RCTs and there is no overview of available methods that disclose these problems.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S2 (checkable).
InterpretationreasoningJudgement using common sense, the literature, and local data can be very helpful in assessing data integrity.
“More importantly, judgement according to common sense, the literature, and local data can be extremely helpful.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S4 (based). May combine two claims.
Interpretationnone givenSome checklist criteria carry more weight than others; any issue involving author group, intervention, or timeframe could be enough to question a study's veracity.
“However, some criteria have more weight than others; for example, any issue regarding author group, intervention, and timeframe could offer enough caution to question the veracity of the study.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S2 (checkable). May combine two claims.
InterpretationreasoningBaseline characteristics and outcomes can provide insight into data integrity and should be assessed methodologically, including for extreme baseline balance and consistency between outcomes.
“Information in baseline characteristics and outcomes can offer insight into integrity.They should be assessed from a methodologic point of view such as extreme balance for baseline characteristics and consistency between outcomes.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationGrey et al. formalized assessment of individual articles, not limited to RCTs, as the REAPPRAISED checklist.
“Grey et al formalized the assessment of individual articles, not restricted to RCTs, as the “REAPPRAISED” checklist.15”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [15]
Not checked in the free run.
May combine two claims.
Interpretationnone givenAlthough most biomedical journals endorse the COPE guidelines, they are not implemented consistently.
“Another concern is that the COPE guidelines, although endorsed by most biomedical journals, are not implemented consistently.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Interpretationnone givenThese registration and ethics problems are usually found in trials determined to be fabricated.
“These issues are usually found in trials that were determined to be fabricated.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationSPRITE complements GRIMMER, has no sample-size limitation, can handle per-cell sample sizes in the thousands, and considers the range of possible raw values.
“SPRITE complements GRIMMER tests.It does not have a sample size limitation and can be used with per-cell sample sizes in the thousands.SPRITE also takes into consideration the range of possible values of the raw data.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [22] source
Not checked in the free run.
May combine two claims.
PremisecitationA survey found that more than 14% of scientists had observed fabrication or falsification at least once among colleagues, while only 2% admitted such behavior themselves.
“A survey found that more than 14% of scientists observed fabrication or falsification at least once among their colleagues but only 2% admitted that they had such behaviors.10”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [10] source
Not checked in the free run.
Probably not a substantial claim: may not pass S4 (based).
Interpretationnone givenAbsent or vague descriptions of research ethics may indicate that a trial lacks ethics approval.
“Similarly, absent or vague descriptions of research ethics may indicate that the trial lacks ethics approval.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Premisenone givenA pilot study used the REAPPRAISED checklist as a screening tool for one journal's editorial work, but no formal validation has been reported.
“A pilot study was conducted in which this checklist was used as a screening tool for editorial works of one journal but no formal validation has been reported.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Interpretationnone givenMost investigations of compromised data integrity begin with suspicious clues about implausible study design, conduct, or reporting.
“Most investigations regarding cases of compromised data integrity are triggered by suspicious clues of implausible study design, conduct, or report.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationSPRITE reconstructs potential discrete data sets using the mean, standard deviation, sample size, and lower and upper bounds of item values.
“SPRITE (Sample Parameter Reconstruction via Iterative Techniques) is a technique for reconstructing potential discrete data sets using basic summary information about a sample, namely the mean, the SD, the sample size, and the lower and upper bounds of the range of item values.22”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [22] source
Not checked in the free run.
May combine two claims.
InterpretationreasoningSeveral methods can assess data integrity using summary statistics without individual participant data, but abnormalities may reflect honest error, poor reporting, or misconduct.
“Several methods can be applied to assess data integrity using summary statistics in publications without individual participant data available (Table 2); however, abnormalities found with summary statistics could be explained by honest error, poor reporting, or misconduct.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S4 (based).
Interpretationnone givenAbsent or retrospective trial registration suggests poor transparency of the trial plan.
“Absent or retrospective registration suggests poor transparency of the trial plan.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe GRIMMER test assesses whether reported measures of variability are possible given the sample size and granularity.
“The GRIMMER (Granularity-Related Inconsistency of Means Mapped to Error Repeats) test allows for testing whether reported measures of variability are possible by assessing whether a reported statistic is consistent with the sample size and granularity.20,21”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
Interpretationnone givenFabricated trials frequently report zero participants lost to follow-up or loss to follow-up that yields perfectly balanced analysis numbers.
“Besides implausible time, we also noticed that fabricated trials frequently reported zero participants lost to follow-up or reported loss to follow-up leading to perfectly balanced numbers for analysis (eg, three groups of 50; two groups of 100).”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S4 (based).
InterpretationreasoningIn obstetrics trials, gestational age and birthweight summary values should be reasonably correlated because fraudulent researchers may ignore necessary correlations between these related parameters.
“For example, when assessing obstetrics trials, one could assess whether summary values of gestational age and birthweight are reasonably correlated because researchers who commit fraud may ignore necessary correlations between these two related parameters.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenA limitation of GRIMMER software is that it only works for sample sizes of 99 or less.
“A limitation of the software is that it only works for a sample size of 99 or less.”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
InterpretationcitationAuthors who commit fraud may create variables that are too similar for unrelated variables, which can be assessed with coefficients of variation.
“Authors who commit fraud may come up with variables that are too similar for unrelated variables.This can be assessed with coefficients of variation.38”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [38] source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThere is ongoing debate about the importance of underlying assumptions, including independent variables, exclusive simple randomization, no rounding of summary statistics, and no publication bias.
“However, there is an ongoing debate about the importance of the underlying assumptions including independent variables, exclusive use of simple randomization, no rounding of summary statistics, and no publication bias.29,30”
Quote in the paperNot a substantial claim0 of 2 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Interpretationnone givenWhen manipulating data, people tend to avoid values far from the mean because such values are more noticeable.
“When manipulating data, people tend to avoid values that are far from the mean as they are more noticeable.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S4 (based).
Interpretationnone givenAn increasing number of methods can be used to assess data integrity in randomized controlled trials.
“A growing number of methods can be applied to assess data integrity in RCTs.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationNo dates should occur before first recruitment, and no events should happen after death or the end of the study.
“For example, no dates should occur before the first recruitment, and, similarly, no events should happen after death or the end of the study.36”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [36] source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Premisenone givenTrial registration and the CONSORT statement are endorsed by most journals as prepublication measures to safeguard RCT trustworthiness.
“Measures to safeguard the trustworthiness of RCTs before publication, mainly trial registration and the CONSORT (Consolidated Standards of Reporting Trials) statement, are endorsed by most journals.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim. May combine two claims.
Premisenone givenCONSORT aims to promote transparent reporting of trial methodology, which is different from detecting data fabrication.
“The latter, however, aims to promote transparent reporting of trial methodology, which is different from the detection of data fabrication.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationFabricated data tend to have no or few missing values, whereas 100% follow-up is extremely rare in real trials.
“Also, fabricated data tend to be perfect in terms of no or few missing values, whereas, in real trials, 100% follow-up is extremely rare.35”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [35] source
Not checked in the free run.
Probably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing), S4 (based).
Interpretationnone givenIt is difficult to fabricate several correlated variables that remain consistent with real data.
“It is difficult to fabricate several variables that are correlated and be consistent with real data.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationCompulsory prospective registration for clinical trials was launched 17 years ago.
“The requirement of compulsory prospective registration for any clinical trials was launched 17 years ago.9”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [9] source
Not checked in the free run.
May combine two claims.
PremisecitationFurther simulation studies suggest that only rounding could significantly alter the expected distribution and that continuous baseline characteristics conform to a uniform distribution.
“Reassuringly, further simulation studies suggest that only rounding could significantly alter the expected distribution, 31 and that continuous baseline characteristics conform to uniform distribution.32”
Quote in the paperSubstantial claim0 of 2 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
PremisereasoningReal participant recruitment or randomization rates are unlikely to be perfectly constant over time because trials usually have a climbing period.
“Also, the rate of real participant recruitment or randomization is unlikely to be perfectly constant over time as recruitments in trials usually have a “climbing” period.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
PremisecitationCentral statistical monitoring compares data from one center with data from other centers using statistical methods.
“Central statistical monitoring refers to comparing data from one center with data from other centers using statistical methods.39”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [39] source
Not checked in the free run.
May combine two claims.
InterpretationreasoningInconsistent retraction practices and failure to state retraction reasons account for the paradoxical finding that some retracted articles are cited more frequently after retraction.
“This explains a paradoxical phenomenon that some retracted articles were cited far more often after their retractions.45”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S4 (based).
InterpretationreasoningManipulated observations might have different characteristics from true observations.
“As a result, manipulated observations might present different characteristics from true observations.”
Quote in the paperNot a substantial claim- The authors state this as an assumption: In central statistical monitoring, it is assumed that anyone who manipulated data did not have access to trial data from other staff or centers.
May combine two claims.
InterpretationreasoningBecause journals do not share submission information with one another, authors who commit research misconduct can easily leave a bad record behind and submit the compromised paper to a different journal.
“Journals do not share information of submissions with their counterparts, which makes it easy for authors who commit research misconduct to walk away from a bad record and submit the compromised paper to another journal.”
Quote in the paperNot a substantial claim- Rests on an assumption: Journals do not share information about submissions with other journals.
May combine two claims.
PremisecitationJournals' retraction practices are inconsistent, and many retractions do not state the reason for retraction.
“At present, journals' retraction practices are inconsistent and many retractions fail to state the reason for retraction.44”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [44]
Not checked in the free run.
Probably not a substantial claim: may not pass S4 (based). May combine two claims.
Interpretationnone givenPublications containing falsified data harm the reputation of journals and publishers, misguide future research, and put patients at risk.
“Publications containing falsified data not only harm the reputation of journals and publishers but also misguide future research and put patients at risk.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationIt might be possible to check whether too many participant visits occurred during weekends or public holidays.
“It might be possible to check whether there are too many participant visits that took place during weekends or public holidays.37”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [37] source
Not checked in the free run.
Probably not a substantial claim: may not pass S4 (based).
Interpretationnone givenThe biggest hurdle for individual-participant-data assessments is the unavailability of data for submitted or published trials.
“However, the biggest hurdle for these assessments is the unavailability of data for submitted or published trials.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisereasoningSome variables should be correlated based on knowledge or common sense; for example, blood loss and hemoglobin drop should be related in a postpartum hemorrhage trial, and the correlation strength should be consistent across treatment groups.
“Some variables should be correlated based on knowledge or common sense; for example, the volume of blood loss and drop in hemoglobin should be related in a trial studying postpartum hemorrhage and, the strength of correlation should be consistent across treatment groups.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationFurther work estimated expected distributions using rounded summary statistics from a large collection of authentic RCTs.
“Further works were also performed to estimate the expected distributions using rounded summary statistics of a large collection of authentic RCTs.33”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [33] source
Not checked in the free run.
The authors state this as an assumption.
In central statistical monitoring, it is assumed that anyone who manipulated data did not have access to trial data from other staff or centers.
“This method is based on an important assumption that anyone who manipulated data did not have access to trial data from other staff or centers.”
The paper relies on this without support.
In most research-misconduct investigations, authors and their institutions do not respond adequately or in a timely manner.
“As one might imagine, in most investigations of research misconduct, neither authors nor their institutions respond adequately in a timely manner.”
The paper relies on this without support.
A lack of willingness to consider integrity issues in published articles often prolongs or prevents retraction of problematic articles.
“Lack of willingness to envisage integrity issues of published articles often prolongs or prevents retraction of problematic articles.”
The paper relies on this without support.
Because regulatory oversight is usually absent, institutions have questionable motivation to investigate their employees' research.
“Given the usual absence of regulatory oversight, the motivation of institutions to investigate the research of their employees is largely questionable.”
The paper relies on this without support.
Journals do not share information about submissions with other journals.
“Journals do not share information of submissions with their counterparts”
The paper relies on this without support.
Editors and journals might have only so much time and resources to check the integrity of each submission.
“Understandably, journals and editors may have limited energy and resources to oversee the integrity of every submission.”
The paper relies on this without support.
The peer-review process was not created to detect integrity issues.
“Peer-review, a mechanism to assess scientific values of submissions, was not de-signed to identify integrity problems.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Li et al. suggested a low author-to-study size ratio or a number of authors less than three should trigger concern.
“Li et al. suggested a low author-to-study size ratio or a number of authors less than three should trigger concern. 39”
From Identifying and managing problematic trials: A research integrity assessment tool for randomized controlled trials in evidence synthesis (2023) · cites this paper as [39]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Database guide access date falls after the paper's publication year
MinorReference 8 says the database guide was accessed in December 2022, but the paper is marked as published in 2021. The stated access date is therefore later than the paper's publication year.
“8. Retraction Watch. Retraction watch database user guide. Ac- cessed December 22, 2022.”
“© 2021 by the American College of Obstetricians and Gynecologists.Published by Wolters Kluwer Health, Inc.”
Cites
2 retracted
(2020) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000003836 · Cited by 5 · see citing works
Retracted(2021) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.16565 · Cited by 2 · see citing works
RetractedFanelli, D. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005738 · Cited by 1,911 · see citing works
Misconduct accounts for the majority of retracted scientific publications
Fang, F. C., Steen, R. G., & Casadevall, A. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1212247109 · Cited by 1,232 · see citing works
Why has the number of scientific retractions increased?
Steen, R. G., Casadevall, A., & Fang, F. C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068397 · Cited by 415 · see citing works
Clinical trial registration: a statement from the International Committee of Medical Journal Editors
De Angelis, C., Drazen, J. M., Frizelle, F. A., Haug, C., Hoey, J., Horton, R., Kotzin, S., Laine, C., Marusic, A., Overbeke, A. J. P., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17034-7 · Cited by 408 · see citing works
Titus, S. L., Wells, J. A., & Rhoades, L. J. (2008) · Nature · doi:10.1038/453980a · Cited by 300 · see citing works
Why and how do journals retract articles? An analysis of Medline retractions 1988–2008
Wager, E., & Williams, P. (2011) · Journal of Medical Ethics · doi:10.1136/jme.2010.040964 · Cited by 263 · see citing works
Naudet, F., Sakarovitch, C., Janiaud, P., Cristea, I., Fanelli, D., Moher, D., & Ioannidis, J. P. A. (2018) · BMJ · doi:10.1136/bmj.k400 · Cited by 227 · see citing works
Retractions in the scientific literature: do authors deliberately commit research fraud?
Steen, R. G. (2011) · Journal of Medical Ethics · doi:10.1136/jme.2010.038125 · Cited by 217 · see citing works
Carlisle, J. B. (2021) · Anaesthesia · doi:10.1111/anae.15263 · Cited by 173 · see citing works
Ensuring trial validity by data quality assurance and diversification of monitoring methods
Baigent, C., Harrell, F. E., Buyse, M., Emberson, J. R., & Altman, D. G. (2008) · Clinical Trials · doi:10.1177/1740774507087554 · Cited by 163 · see citing works
Brown, N. J. L., & Heathers, J. A. J. (2017) · Social Psychological and Personality Science · doi:10.1177/1948550616673876 · Cited by 127 · see citing works
Check for publication integrity before misconduct
Grey, A., Bolland, M. J., Avenell, A., Klein, A. A., & Gunsalus, C. K. (2020) · Nature · doi:10.1038/d41586-019-03959-6 · Cited by 114 · see citing works
Systematic review and statistical analysis of the integrity of 33 randomized controlled trials
Bolland, M. J., Avenell, A., Gamble, G. D., & Grey, A. (2016) · Neurology · doi:10.1212/wnl.0000000000003387 · Cited by 111 · see citing works
Chambers, L., Michener, C., & Falcone, T. (2019) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.15689 · Cited by 99 · see citing works
Carlisle, J. B., Dexter, F., Pandit, J. J., Shafer, S. L., & Yentis, S. M. (2015) · Anaesthesia · doi:10.1111/anae.13126 · Cited by 87 · see citing works
Application of methods for central statistical monitoring in clinical trials
Kirkwood, A. A., Cox, T., & Hackshaw, A. (2013) · Clinical Trials · doi:10.1177/1740774513494504 · Cited by 75 · see citing works
Data integrity of 35 randomised controlled trials in women' health
Bordewijk, E. M., Wang, R., Askie, L. M., Gurrin, L. C., Thornton, J. G., van Wely, M., Li, W., & Mol, B. W. (2020) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2020.04.016 · Cited by 66 · see citing works
Self-citationEvidence for non‐random sampling in randomised, controlled trials by Yuhji Saitoh
Carlisle, J. B., & Loadsman, J. A. (2017) · Anaesthesia · doi:10.1111/anae.13650 · Cited by 64 · see citing works
Evidence for compromised data integrity in studies of liberal peri‐operative inspired oxygen
Myles, P. S., Carlisle, J. B., & Scarr, B. (2019) · Anaesthesia · doi:10.1111/anae.14584 · Cited by 64 · see citing works
Dal-Ré, R., Ross, J. S., & Marušić, A. (2016) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2016.01.017 · Cited by 55 · see citing works
Rockhold, F., Nisen, P., & Freeman, A. (2016) · New England Journal of Medicine · doi:10.1056/nejmp1608086 · Cited by 55 · see citing works
Heathers, J. A., Anaya, J., van der Zee, T., & Brown, N. J. (2018) · PeerJ Preprints · doi:10.7287/peerj.preprints.26968v1 · Cited by 44 · see citing works
Empirically generated reference proportions for baseline p values from rounded summary statistics
Bolland, M. J., Gamble, G. D., Grey, A., & Avenell, A. (2020) · Anaesthesia · doi:10.1111/anae.15165 · Cited by 37 · see citing works
Randomised controlled trials evaluating endometrial scratching: assessment of methodological issues
Li, W., Suke, S., Wertaschnigg, D., Lensen, S., Wang, R., Gurrin, L., & Mol, B. W. (2019) · Human Reproduction · doi:10.1093/humrep/dez207 · Cited by 36 · see citing works
Self-citationTrialists' intent to share individual participant data as disclosed at ClinicalTrials.gov
Bergeris, A., Tse, T., & Zarin, D. A. (2018) · JAMA · doi:10.1001/jama.2017.20581 · Cited by 34 · see citing works
The GRIMMER test: A method for testing the validity of reported measures of variability
Anaya, J. (2016) · PeerJ Preprints · doi:10.7287/peerj.preprints.2400v1 · Cited by 31 · see citing works
Bolland, M. J., Gamble, G. D., Avenell, A., & Grey, A. (2019) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2019.03.001 · Cited by 31 · see citing works
An appraisal of the Carlisle-Stouffer-Fisher method for assessing study data integrity and fraud
Mascha, E. J., Vetter, T. R., & Pittet, J.-F. (2017) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000002415 · Cited by 30 · see citing works
Bolland, M. J., Gamble, G. D., Avenell, A., Grey, A., & Lumley, T. (2019) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2019.05.006 · Cited by 27 · see citing works
Scientific fraud in 20 falsified anesthesia papers: Detection using financial auditing methods
Hein, J., Zobrist, R., Konrad, C., & Schuepfer, G. (2012) · Der Anaesthesist · doi:10.1007/s00101-012-2029-x · Cited by 25 · see citing works
Hüllemann, S., Schüpfer, G., & Mauch, J. (2017) · Der Anaesthesist · doi:10.1007/s00101-017-0333-1 · Cited by 25 · see citing works
van den Bor, R. M., Vaessen, P. W. J., Oosterman, B. J., Zuithoff, N. P. A., Grobbee, D. E., & Roes, K. C. B. (2017) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2017.03.018 · Cited by 22 · see citing works
Knepper, D., Lindblad, A. S., Sharma, G., Gensler, G. R., Manukyan, Z., Matthews, A. G., & Seifu, Y. (2016) · Therapeutic Innovation & Regulatory Science · doi:10.1177/2168479016630576 · Cited by 19 · see citing works
Heathers, J. A. J., Anaya, J., van der Zee, T., & Brown, N. J. L. (2018) · doi:10.7287/peerj.preprints.26968 · Cited by 19 · see citing works
Bordewijk, E. M., Wang, R., van Wely, M., Costello, M. F., Norman, R. J., Teede, H., Gurrin, L. C., Mol, B. W., & Li, W. (2020) · Human Reproduction Update · doi:10.1093/humupd/dmaa031 · Cited by 18 · see citing works
Self-citationThe Oxford handbook of the science of science communication
Jamieson, K. H., Kahan, D. M., & Scheufele, D. A. (2017) · Cited by 16 · see citing works
Seeking and reporting apparent research misconduct: errors and integrity
Kharasch, E. D., & Houle, T. T. (2018) · Anaesthesia · doi:10.1111/anae.14147 · Cited by 15 · see citing works
Hudes, M. L., McCann, J. C., & Ames, B. N. (2009) · The FASEB Journal · doi:10.1096/fj.08-108910 · Cited by 12 · see citing works
Understand low-quality evidence: learn from food chains
Wang, R., & van Wely, M. (2020) · Fertility and Sterility · doi:10.1016/j.fertnstert.2019.11.026 · Cited by 6 · see citing works
The GRIMMER test: A method for testing the validity of reported measures of variabilityPreprint
Anaya, J. (2016) · doi:10.7287/peerj.preprints.2400 · Cited by 6 · see citing works
Li, W., & Mol, B. W. (2019) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.15829 · Cited by 5 · see citing works
Self-citationBuyse, M. (1999) · doi:10.1002/(sici)1097-0258(19991230)18:24
Flagged first, then by citations
Cited by
Sorted by citations
A checklist to assess Trustworthiness in RAndomised Controlled Trials (TRACT checklist)
Mol, B. W., Lai, S., Rahim, A., Bordewijk, E. M., Wang, R., Eekelen, R. V., Gurrin, L. C., Thornton, J. G., Wely, M. V., & Li, W. (2023) · doi:10.21203/rs.3.rs-2119486/v1 · Cited by 149 · see citing works
Self-citationMol, B. W., Lai, S., Rahim, A., Bordewijk, E. M., Wang, R., van Eekelen, R., Gurrin, L. C., Thornton, J. G., van Wely, M., & Li, W. (2023) · Research Integrity and Peer Review · doi:10.1186/s41073-023-00130-8 · Cited by 141 · see citing works
“Based on our experience and a subsequent systematic scoping review that assessed current methods of assessing research misconduct [16], we developed a prototype checklist to screen for trustworthiness issues due to possible scientific misconduct in RCTs [17].”
BackgroundSelf-citationWeibel, S., Popp, M., Reis, S., Skoetz, N., Garner, P., & Sydenham, E. (2023) · Research Synthesis Methods · doi:10.1002/jrsm.1599 · Cited by 93 · see citing works
“suggested a low author-to-study size ratio or a number of authors less than three should trigger concern.(39) If there are concerns regarding a study's author group, a request should be sent to the authors and the RCT should be moved to the pool of studies awaiting classification until clarified.”
BackgroundParker, L., Boughton, S., Lawrence, R., & Bero, L. (2022) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2022.07.006 · Cited by 45 · see citing works
Mousa, A., Flanagan, M., Tay, C. T., Norman, R. J., Costello, M., Li, W., Wang, R., Teede, H. J., & Mol, B. W. (2024) · EClinicalMedicine · doi:10.1016/j.eclinm.2024.102717 · Cited by 40 · see citing works
Self-citationViolation of research integrity principles occurs more often than we think
Li, W., Gurrin, L. C., & Mol, B. W. (2021) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2021.11.022 · Cited by 33 · see citing works
Self-citationTurner, J., Russo, F. M., Deprest, J. A., Mol, B. W., & Kumar, S. (2022) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.17163 · Cited by 28 · see citing works
Self-citationThe Individual Participant Data Integrity Tool for assessing the integrity of randomised trials
Hunter, K. E., Aberoumand, M., Libesman, S., Sotiropoulos, J. X., Williams, J. G., Aagerup, J., Wang, R., Mol, B. W., Li, W., Barba, A., et al. (2024) · Research Synthesis Methods · doi:10.1002/jrsm.1738 · Cited by 28 · see citing works
Self-citationKhan, K. S., Fawzy, M., & Chien, P. F. W. (2023) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.14837 · Cited by 20 · see citing works
Tranexamic acid for preventing postpartum haemorrhage after caesarean section
Rohwer, C., Rohwer, A. C., Cluver, C. A., Ker, K., & Hofmeyr, G. J. (2024) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd016278 · Cited by 20 · see citing works
Steinberg, J. R., Magnani, C. J., Turner, B. E., Weeks, B. T., Young, A. M. P., Lu, C. F., Zhang, N., Richardson, M. T., Fitzgerald, A. C., Mekonnen, Z. K., et al. (2022) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000004735 · Cited by 19 · see citing works
Tranexamic acid for preventing postpartum haemorrhage after vaginal birth
Rohwer, C., Rohwer, A. C., Cluver, C. A., Ker, K., & Hofmeyr, G. J. (2025) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007872.pub4 · Cited by 14 · see citing works
Assessing Research Misconduct in Randomized Controlled Trials
Khan, K. S. (2021) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000004622 · Cited by 10 · see citing works
Protecting data integrity in reproductive medicine
Fauser, B. C. J. M. (2021) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2021.12.005 · Cited by 10 · see citing works
Hunter, K. E., Aberoumand, M., Libesman, S., Sotiropoulos, J. X., Williams, J. G., Li, W., Aagerup, J., Mol, B. W., Wang, R., Barba, A., et al. (2024) · Research Synthesis Methods · doi:10.1002/jrsm.1739 · Cited by 8 · see citing works
Self-citationHunter, K., Aberoumand, M., Libesman, S., Sotiropoulos, J., Williams, J., Li, W., Aagerup, J., Mol, B., Wang, R., Barba, A., et al. (2023) · doi:10.1101/2023.12.11.23299797 · Cited by 9 · see citing works
Self-citationScientific Misconduct in the Era of Artificial Intelligence: Insights From the Global South
Sozon, M., & Parnther, C. (2025) · Higher Education Quarterly · doi:10.1111/hequ.70097 · Cited by 7 · see citing works
Minetto, S., Zanirato, M., Makieva, S., Marzanati, D., Esposito, S., Pisaturo, V., Costa, M., Candiani, M., Papaleo, E., & Alteri, A. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1210951 · Cited by 7 · see citing works
Breuking, S., de Ruigh, A. A., Hermans, F. J. R., Schuit, E., Combs, C. A., de Tejada, B. M., Oudijk, M. A., Mol, B. W., & Pajkrt, E. (2023) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.17499 · Cited by 7 · see citing works
Self-citationOn the value of meta‐research for early career researchers: A commentary
Fabiano, N., Gupta, A. A., Fiedorowicz, J. G., & Solmi, M. (2024) · JCPP Advances · doi:10.1002/jcv2.12235 · Cited by 7 · see citing works
Preventing postpartum hemorrhage: A network meta-analysis on routes of administration of uterotonics
Papadopoulou, A., Tournas, G., Georgiopoulos, G. A., Antsaklis, P., Daskalakis, G., Coomarasamy, A., & Devall, A. (2024) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2024.02.021 · Cited by 5 · see citing works
Concerns about data integrity across 263 papers by one author
Nielsen, J., Flanagan, M., Gurrin, L. C., Thornton, J., & Mol, B. W. (2024) · Journal of Gynecology Obstetrics and Human Reproduction · doi:10.1016/j.jogoh.2024.102794 · Cited by 5 · see citing works
Self-citationRed for danger in systematic reviews?
Moore, A. (2021) · European Journal of Hospital Pharmacy · doi:10.1136/ejhpharm-2021-003080 · Cited by 5 · see citing works
Trustworthiness assessment of published clinical trials: Literature review of domains and questions
Alfirević, Ž., & Weeks, J. (2024) · Cochrane Evidence Synthesis and Methods · doi:10.1002/cesm.12099 · Cited by 3 · see citing works
The randomized clinical trial trustworthiness crisis
Butt, F., Fawzy, M. M., Wattar, B. H. A., Bueno‐Cavanillas, A., Khan, K. S., & Khalaf, Y. (2024) · Middle East Fertility Society Journal · doi:10.1186/s43043-023-00161-7 · Cited by 2 · see citing works
Advancing data honesty in experimental biology
Dubiner, S., & Arbel, M. (2024) · Journal of Experimental Biology · doi:10.1242/jeb.247383 · Cited by 2 · see citing works
Lawson, S., Doulaveris, G., Anderson, K., Bennett, C., & Berghella, V. (2025) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2025.03.047 · Cited by 2 · see citing works
Breuking, S., de Ruigh, A. A., Merced, C., van EEKELEN, R., van Wely, M., van Dijk, C. E., Pratcorona, L., Carreras, E., Mol, B. W., Saccone, G., et al. (2025) · American Journal of Obstetrics & Gynecology MFM · doi:10.1016/j.ajogmf.2025.101690 · Cited by 2 · see citing works
Self-citationFlanagan, M., Rattan, A., Au, L. S., Patabendige, M., Whigham, C., Jans, S. M. P. J., Cofie, P., Hofmeyr, G. J., Rosseland, L. A., Weeks, A. D., et al. (2025) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.18279 · Cited by 3 · see citing works
Self-citationParker, L., Boughton, S. L., Lawrence, R., & Bero, L. A. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4071671 · Cited by 2 · see citing works
Challenges in Interpreting Obstetrics and Gynecology Literature.
Bruno, A. M., & Blue, N. R. (2022) · PubMed · doi:10.1097/grf.0000000000000707 · Cited by 1 · see citing works
Research misconduct - The tarnishing agent in medical research
Ojha, M. (2026) · Current Medicine Research and Practice · doi:10.4103/cmrp.cmrp_126_25 · Cited by 1 · see citing works
Yang, Y., Yang, S., Han, Y., Zou, G., Wang, R., & Liu, L. (2024) · Scientific Reports · doi:10.1038/s41598-024-57514-z · Cited by 1 · see citing works
Abbott, J. A., Hopkins, M. R., & King, L. P. (2022) · Journal of Minimally Invasive Gynecology · doi:10.1016/j.jmig.2022.03.017 · Cited by 1 · see citing works
Maintaining Academic Integrity of Our Journal
Falcone, T. (2022) · Journal of Minimally Invasive Gynecology · doi:10.1016/j.jmig.2022.04.003 · Cited by 1 · see citing works
Li, W., Bordewijk, E. M., & Mol, B. W. (2021) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000004623
Self-citationMol, B. W., Lai, S., Rahim, A., Bordewijk, E. M., Wang, R., van EEKELEN, R., Gurrin, L. C., Thornton, J. G., van Wely, M., & Li, W. (2024) · Figshare · doi:10.6084/m9.figshare.26593376
Self-citationAdditional file 1 of The randomized clinical trial trustworthiness crisis
Butt, F. A., Fawzy, M. M., Wattar, B. H. A., Bueno‐Cavanillas, A., Khan, K. S., & Khalaf, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26658337
- Authors
- Li, W., Bordewijk, E. M., & Mol, B. W.
- Affiliations
- University of Aberdeen (GB)
- Venue
- Obstetrics & Gynecology
- Published
- 2021-08-04
- Volume
- 138
- Issue
- 3
- Pages
- 338-347
- ISSN
- 0029-7844 (ISSN-L)
- OpenAlex
- W3187755343
- Semantic Scholar
- 580d2837b14fe64fa92a03c4fe288519b550b06c
- Cited by
- 37
- References
- 44
- Citations by year
- 2026: 1 · 2025: 5 · 2024: 13 · 2023: 4 · 2022: 9 · 2021: 5
- FWCI
- 1.45
- Type
- journal article
- Language
- en
- Open access
- green
- pure.amsterdamumc.nl
- Licence
- other-oa
- Locations
- Obstetrics and Gynecology (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (submittedVersion, other-oa)
- Funders
- National Health and Medical Research Council (1176437)
- Topics
- Social Sciences › Safety Research › Academic integrity and plagiarism
- Physical Sciences › Mathematics › Statistics and Probability › Benford’s Law and Fraud Detection
- Social Sciences › Decision Sciences › Information Systems and Management › Academic Publishing and Open Access
- Keywords
- research misconduct, randomized controlled trials, data integrity, data manipulation, retraction, authorship patterns, evidence synthesis, patient protection
- MeSH terms
- Female, Gynecology, Humans, Obstetrics, Periodicals as Topic, Pregnancy, Scientific Misconduct, Randomized Controlled Trials as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-05.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-05.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review